Extended-release formulations: Simplifying strategies in the management of antiepileptic drug therapy

Epilepsy and Behavior

Volumn 5, Issue 3, 2004, Pages 301-307

  Pellock, John M ^a   Smith, Michael C ^b   Cloyd, James C ^c   Uthman, Basim ^d,e   Wilder, B J ^d  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RUSH MEDICAL COLLEGE   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Carbamazepine; Compliance; Divalproex; Epilepsy; Extended release; Once daily dosing; Phenytoin

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; TOPIRAMATE; VALPROATE SEMISODIUM;

ATAXIA; CLINICAL TRIAL; CONFUSION; CONTROLLED RELEASE FORMULATION; DIPLOPIA; DIZZINESS; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG HALF LIFE; EPILEPSY; HUMAN; LIFESTYLE; PATIENT CARE; PATIENT COMPLIANCE; PATIENT SATISFACTION; QUALITY OF LIFE; REVIEW; SEDATION; SEIZURE; SIDE EFFECT; SOMNOLENCE; DELAYED RELEASE FORMULATION; TIME; TREATMENT OUTCOME;

ANTICONVULSANTS; DELAYED-ACTION PREPARATIONS; EPILEPSY; HUMANS; TIME FACTORS; TREATMENT OUTCOME;

EID: 3042677985     PISSN: 15255050     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yebeh.2004.01.009     Document Type: Review

References (35)

1. Annegers J.F. Epidemiology of epilepsy Wyllie E. (Ed.). The treatment of epilepsy: principles and practice 2nd ed. 1997 165-172 Williams & Wilkins Baltimore
2. Hauser W.A. Hesdorffer D.C. Epilepsy: frequency, causes and consequences 1990 Demos New York
3. Mattson R.H. Cramer J.A. Collins J.F. Prognosis for total control of complex partial and secondarily generalized tonic clonic seizures. Department of Veterans Affairs Epilepsy Cooperative Studies No. 118 and No. 264 Group Neurology 47 1996 68-76
4. Kwan P. Brodie M.J. Early identification of refractory epilepsy N. Engl. J. Med 342 2000 314-319
5. Cramer J.A. Mattson R.H. Prevey M.L. Scheyer R.D. Ouellette V.L. How often is medication taken as prescribed? A novel assessment technique JAMA 261 1989 3273-3277
6. Cramer J.A. Glassman M. Rienzi B.A. The relationship between poor medication compliance and seizures Epilepsy Behav. 3 2002 338-342
7. Pedley T.A. Scheuer M.L. Walczak T.S. Epilepsy Rowland L.P. Merritt's textbook of neurology 9th ed. 1995 845-868 Williams & Wilkins Baltimore, MD
8. Leppik I.E. Contemporary diagnosis and management of the patient with epilepsy 6th ed. 2002 Handbooks in Healthcare Newtown, PA
9. Heller A.J. Chesterman P. Elwes R.D. et al. Phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed adult epilepsy: a randomised comparative monotherapy trial J. Neurol. Neurosurg. Psychiatry 58 1995 44-50
10. Chadwick D. Standard approach to antiepileptic drug treatment in the United Kingdom Epilepsia 35 Suppl 4 1994 S3-S10
11. Pellock J.M. Standard approach to antiepileptic drug treatment in the United States Epilepsia 35 Suppl 4 1994 S11-S18
12. Cloyd J.C. Remmel R.P. Antiepileptic drug pharmacokinetics and interactions: impact on treatment of epilepsy Pharmacotherapy 20 8, Pt 2 2000 139S-151S
13. Hoppener R.J. Kuyer A. Meijer J.W. Hulsman J. Correlation between daily fluctuations of carbamazepine serum levels and intermittent side effects Epilepsia 21 1980 341-350
14. Rowan A.J. Pippenger C.E. McGregor P.A. French J.H. Seizure activity and anticonvulsant drug concentration Arch Neurol 32 1975 281-288
15. Dutta S. Zhang Y. Selness D.S. Lee L.L. Williams L.A. Sommerville K.W. Comparison of the bioavailability of unequal doses of divalproex sodium extended-release formulation relative to the delayed-release formulation in healthy volunteers Epilepsy Res. 49 2002 1-10
16. Sommerville K.W. Dutta S. Biton V. Zhang Y. Cloyd J.C. Uthman B. Bioavailability of a divalproex extended-release formulation versus the conventional divalproex formulation in adult patients receiving enzyme-inducing antiepileptic drug Clin. Drug Invest. 23 2003 661-670
17. Dutta S, Zhang Y, Conway JM, Salle FR, Biton V, Reed MD, Kearns GL. Divalproex-ER pharmacokinetics in older children and adolescents. Ped Neurology, (in press, 2004)
18. Zielinski D. Smith M.C. The use of extended release formulation of divalproex in patients with epilepsy Epilepsia 42 Suppl 7 2001 92
19. Garnett W.R. Levy B. McLean A.M. et al. Pharmacokinetic evaluation of twice-daily extended-release carbamazepine (CBZ) and four-times-daily immediate-release CBZ in patients with epilepsy Epilepsia 39 1998 274-279
20. Thakker K.M. Mangat S. Garnett W.R. Levy R.H. Kochak G.M. Comparative bioavailability and steady state fluctuations of Tegretol commercial and carbamazepine OROS tablets in adult and pediatric epileptic patients Biopharm Drug Dispos 13 1992 559-569
21. Miller A. Bergey G. Krauss G. Conversion from immediate- to extended-release carbamazepine markedly reduces CNS-related side effects in patients with partial-onset epilepsy Epilepsia 43 Suppl 7 2002 196
22. Huang M.-Y. Individual bioequivalence analysis of Bertek's Phenytek™ (1 × 300 mg extended phenytoin sodium) versus Parke-Davis' Dilantin® Kapseals® (3 × 100 mg) Epilepsia 43 Suppl 7 2002 105
23. Bourgeois B.F. Reducing overtreatment Epilepsy Res 52 2002 53-60
24. Levy R.H. Mattson R.H. Meldrum B.S. Perucca E. Antiepileptic drugs 5th ed. 2002 Lippincott, Wilkins & Williams Philadelphia
25. Kudriakova T.B. Sirota L.A. Rozova G.I. Gorkov V.A. Autoinduction and steady-state pharmacokinetics of carbamazepine and its major metabolites Br. J. Clin. Pharmacol. 33 1992 611-615
26. Pellock J.M. Dodson W.E. Bourgeois B.F. Pediatric epilepsy: diagnosis and therapy 2nd ed. 2001 Demos New York
27. Leppik I.E. Wyllie E. The treatment of epilepsy: principles and practice 3rd ed. 2001 787-794 Lippincott, Wilkins & Williams Philadelphia
28. Ramsay R.E. Pryor F. Epilepsy in the elderly Neurology 55 5, Suppl 1 2000 S9-S14
29. Devinsky O. Yerby M.S. Women with epilepsy: reproduction and effects of pregnancy on epilepsy Neurol. Clin. 12 1994 479-495
30. Schachter S.C. Antiepileptic drug therapy: general treatment principles and application for special patient populations Epilepsia 40 Suppl 9 1999 S20-S25
31. Practice parameter: management issues for women with epilepsy (summary statement). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 1998;51:944-8
32. ACOG educational bulletin No. 231: Seizure disorders in pregnancy, December 1996. Committee on Educational Bulletins of the American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 1997;56:279-86
33. Abbasi F. Krumholz A. Kittner S.J. Langenberg P. Effects of menopause on seizures in women with epilepsy Epilepsia 40 1999 205-210
34. Pellock J.M. Managing pediatric epileptic syndromes with new antiepileptic drugs Pediatrics 104 1999 1106-1111
35. Brodie M.J. French J.A. Management of epilepsy in adolescents and adults Lancet 356 2000 323-329